These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15378016)

  • 41. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional implication of truncated P-cadherin expression in malignant melanoma.
    Bauer R; Bosserhoff AK
    Exp Mol Pathol; 2006 Dec; 81(3):224-30. PubMed ID: 16919267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.
    Pećina-Slaus N; Zigmund M; Kusec V; Martić TN; Cacić M; Slaus M
    J Cutan Pathol; 2007 Mar; 34(3):239-46. PubMed ID: 17302608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.
    Meyskens FL; Buckmeier JA; McNulty SE; Tohidian NB
    Clin Cancer Res; 1999 May; 5(5):1197-202. PubMed ID: 10353757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells.
    Padovan E; Terracciano L; Certa U; Jacobs B; Reschner A; Bolli M; Spagnoli GC; Borden EC; Heberer M
    Cancer Res; 2002 Jun; 62(12):3453-8. PubMed ID: 12067988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
    Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
    Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-cadherin counteracts myosin II-B function: implications in melanoma progression.
    Jacobs K; Van Gele M; Forsyth R; Brochez L; Vanhoecke B; De Wever O; Bracke M
    Mol Cancer; 2010 Sep; 9():255. PubMed ID: 20860798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.
    Poser I; Golob M; Buettner R; Bosserhoff AK
    Mol Cell Biol; 2003 Apr; 23(8):2991-8. PubMed ID: 12665595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from
    Lallo S; Hardianti B; Sartini S; Ismail I; Laela D; Hayakawa Y
    Life (Basel); 2022 Feb; 12(3):. PubMed ID: 35330088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-Professional Phagocytosis Increases in Melanoma Cells and Tissues with Increasing E-Cadherin Expression.
    Unseld LH; Hildebrand LS; Putz F; Büttner-Herold M; Daniel C; Fietkau R; Distel LV
    Curr Oncol; 2023 Aug; 30(8):7542-7552. PubMed ID: 37623028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Snail puts melanoma on the fast track.
    Herzinger T; Wolf DA
    Pigment Cell Melanoma Res; 2009 Apr; 22(2):150-1. PubMed ID: 19302129
    [No Abstract]   [Full Text] [Related]  

  • 52. The Impact of Excision Interval on Equine Melanoma Progression: Time Matters?
    Pimenta J; Prada J; Pires I; Cotovio M
    Animals (Basel); 2024 Apr; 14(8):. PubMed ID: 38672392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype.
    Oh A; Pardo M; Rodriguez A; Yu C; Nguyen L; Liang O; Chorzalska A; Dubielecka PM
    Cell Commun Signal; 2023 Oct; 21(1):291. PubMed ID: 37853467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
    Trono P; Tocci A; Palermo B; Di Carlo A; D'Ambrosio L; D'Andrea D; Di Modugno F; De Nicola F; Goeman F; Corleone G; Warren S; Paolini F; Panetta M; Sperduti I; Baldari S; Visca P; Carpano S; Cappuzzo F; Russo V; Tripodo C; Zucali P; Gregorc V; Marchesi F; Nistico P
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37612043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment.
    Lin WH; Cooper LM; Anastasiadis PZ
    Front Cell Dev Biol; 2023; 11():1137013. PubMed ID: 37255594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis.
    Neuendorf HM; Simmons JL; Boyle GM
    Front Cell Dev Biol; 2023; 11():1183328. PubMed ID: 37181747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pro-inflammatory role of Wnt/β-catenin signaling in endothelial dysfunction.
    Wadey KS; Somos A; Leyden G; Blythe H; Chan J; Hutchinson L; Poole A; Frankow A; Johnson JL; George SJ
    Front Cardiovasc Med; 2022; 9():1059124. PubMed ID: 36794234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness.
    Cabaço LC; Tomás A; Pojo M; Barral DC
    Front Oncol; 2022; 12():887366. PubMed ID: 35619912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptional Control of Apical-Basal Polarity Regulators.
    Rust K; Wodarz A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy.
    Mazurkiewicz J; Simiczyjew A; Dratkiewicz E; Ziętek M; Matkowski R; Nowak D
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.